US 10787462
Heterocyclic compound
granted A61KA61K31/55A61K31/553
Quick answer
US patent 10787462 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/55, A61K31/553, A61K31/554, A61P